The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Global Prevalence of Fetal Alcohol Spectrum Disorder Among Children and Youth: A Systematic Review and Meta-analysis
Open accessAbstract
Importance: Prevalence estimates are essential to effectively prioritize, plan, and deliver health care to high-needs populations such as children and youth with fetal alcohol spectrum disorder (FASD). However, most countries do not have population-level prevalence data for FASD. Objective: To obtain prevalence estimates of FASD among children and youth in the general population by country, by World Health Organization (WHO) region, and globally. Data Sources: MEDLINE, MEDLINE in process, EMBASE, Education Resource Information Center, Cumulative Index to Nursing and Allied Health Literature, Web of Science, PsychINFO, and Scopus were systematically searched for studies published from November 1, 1973, through June 30, 2015, without geographic or language restrictions. Study Selection: Original quantitative studies that reported the prevalence of FASD among children and youth in the general population, used active case ascertainment or clinic-based methods, and specified the diagnostic guideline or case definition used were included. Data Extraction and Synthesis: Individual study characteristics and prevalence of FASD were extracted. Country-specific random-effects meta-analyses were conducted. For countries with 1 or no empirical study on the prevalence of FASD, this indicator was estimated based on the proportion of women who consumed alcohol during pregnancy per 1 case of FASD. Finally, WHO regional and global mean prevalence of FASD weighted by the number of live births in each country was estimated. Main Outcomes and Measures: Prevalence of FASD. Results: A total of 24 unique studies including 1416 unique children and youth diagnosed with FASD (age range, 0-16.4 years) were retained for data extraction. The global prevalence of FASD among children and youth in the general population was estimated to be 7.7 per 1000 population (95% CI, 4.9-11.7 per 1000 population). The WHO European Region had the highest prevalence (19.8 per 1000 population; 95% CI, 14.1-28.0 per 1000 population), and the WHO Eastern Mediterranean Region had the lowest (0.1 per 1000 population; 95% CI, 0.1-0.5 per 1000 population). Of 187 countries, South Africa was estimated to have the highest prevalence of FASD at 111.1 per 1000 population (95% CI, 71.1-158.4 per 1000 population), followed by Croatia at 53.3 per 1000 population (95% CI, 30.9-81.2 per 1000 population) and Ireland at 47.5 per 1000 population (95% CI, 28.0-73.6 per 1000 population). Conclusions and Relevance: Globally, FASD is a prevalent alcohol-related developmental disability that is largely preventable. The findings highlight the need to establish a universal public health message about the potential harm of prenatal alcohol exposure and a routine screening protocol. Brief interventions should be provided, where appropriate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
RECOGNITION OF THE FETAL ALCOHOL SYNDROME IN EARLY INFANCY
Jones, K., & Smith, D. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91092-1 · Cited by 2,755
Cited by
Prevalence of Fetal Alcohol Spectrum Disorders in 4 US Communities
May, P. A., Chambers, C. D., Kalberg, W. O., Zellner, J., Feldman, H., Buckley, D., Kopald, D., Hasken, J. M., Xu, R., Honerkamp-Smith, G., et al. (2018) · JAMA · doi:10.1001/jama.2017.21896 · Cited by 807
Arcsine‐based transformations for meta‐analysis of proportions: Pros, cons, and alternatives
Lin, L., & Xu, C. (2020) · Health Science Reports · doi:10.1002/hsr2.178 · Cited by 339
Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder
Wozniak, J. R., Riley, E. P., & Charness, M. E. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30150-4 · Cited by 327
Fetal alcohol spectrum disorders
Popova, S., Charness, M. E., Burd, L., Crawford, A., Hoyme, H. E., Mukherjee, R. A. S., Riley, E. P., & Elliott, E. J. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00420-x · Cited by 307
Self-citationGómez-Roig, M. D., Pascal, R., Cahuana, M. J., García-Algar, O., Sebastiani, G., Andreu-Fernández, V., Martínez, L., Rodríguez, G., Iglesia, I., Ortiz-Arrabal, O., et al. (2021) · Fetal Diagnosis and Therapy · doi:10.1159/000514884 · Cited by 207
Mossink, B., Negwer, M., Schubert, D., & Nadif Kasri, N. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03714-5 · Cited by 114
Chastain, L. G., Franklin, T., Gangisetty, O., Cabrera, M. A., Mukherjee, S., Shrivastava, P., Jabbar, S., & Sarkar, D. K. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0326-7 · Cited by 72
Mukherjee, R. A. S., Cook, P. A., Norgate, S. H., & Price, A. D. (2019) · Alcohol · doi:10.1016/j.alcohol.2018.06.002 · Cited by 63
The relevance of social and commercial determinants for neurological health
Walsh, S., Merrick, R., & Brayne, C. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00428-8 · Cited by 55
Wang, X., Cuzon Carlson, V. C., Studholme, C., Newman, N., Ford, M. M., Grant, K. A., & Kroenke, C. D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919048117 · Cited by 31
Rotheram-Borus, M. J., Arfer, K. B., Christodoulou, J., Comulada, W. S., Stewart, J., Tubert, J. E., & Tomlinson, M. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000408 · Cited by 22
Wechsberg, W. M., Browne, F. A., Ndirangu, J., Bonner, C. P., Kline, T. L., Gichane, M., & Zule, W. A. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03251-7 · Cited by 16
Current Interventions for People Living with HIV Who Use Alcohol: Why Gender Matters
Wechsberg, W. M., Browne, F. A., Bonner, C. P., Washio, Y., Howard, B. N., & van der Drift, I. (2021) · Current HIV/AIDS Reports · doi:10.1007/s11904-021-00558-x · Cited by 10
Washio, Y., Browne, F. A., Ndirangu, J., Kline, T. L., & Wechsberg, W. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18147446 · Cited by 6
Winarni, T. I., Aishworiya, R., Culpepper, H., Zafarullah, M., Mendoza, G., Wilaisakditipakorn, T. J., Likhitweerawong, N., Law, J., Hagerman, R., & Tassone, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072840 · Cited by 3
Metadata
- Authors
- Lange, S., Probst, C., Gmel, G., Rehm, J., Burd, L., & Popova, S.
- Venue
- JAMA Pediatrics
- Publisher
- American Medical Association (AMA)
- Published
- 2017-10-01
- Volume
- 171
- Issue
- 10
- Pages
- 948
- ISSN
- 1072-4710 (ISSN-L)
- 2168-6203
- OpenAlex
- W2746656553
- Cited by
- 669
- References
- 77
- FWCI
- 49.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.